PFEbenzinga

UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients

Summary

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 2, 2025 by benzinga